Drug profile · INN
nisoldipine
NISOLDIPINE
nisoldipine (NISOLDIPINE) is a voltage-gated l-type calcium channel blocker. Route of administration: oral. Current US regulatory status: approved.
Drug details — nisoldipine
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 1
- Programs
- 0
- Data quality
- 0.84
Quick answer
nisoldipine (NISOLDIPINE) is a voltage-gated l-type calcium channel blocker. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Voltage-gated L-type calcium channel blocker
Primary target: Voltage-gated L-type calcium channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Related patents
Frequently asked questions
What is nisoldipine?
nisoldipine (NISOLDIPINE) is a voltage-gated l-type calcium channel blocker. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for nisoldipine?
NISOLDIPINE is a marketed brand name for nisoldipine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nisoldipine?
nisoldipine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.